The Will Rogers phenomenon, Breast Cancer and Race
Autor: | Eswar K. Mundra, Mary R Nittala, Shawn McKinney, Divyang Mehta, Srinivasan Vijayakumar, William C. Woods, Maria L. Smith, Barbara S. Craft, Satyaseelan Packianathan |
---|---|
Rok vydání: | 2020 |
Předmět: |
Oncology
Cancer Research Kaplan-Meier Estimate Tumor grade 0302 clinical medicine Mississippi Breast cancer Surgical oncology 030212 general & internal medicine Breast Racial disparities RC254-282 Aged 80 and over Academic Medical Centers Neoplasms. Tumors. Oncology. Including cancer and carcinogens Middle Aged Prognosis Survival Rate 030220 oncology & carcinogenesis Cohort symbols Female Stage IIIa Research Article Adult medicine.medical_specialty Breast Neoplasms Will Rogers phenomenon Disease-Free Survival White People Stage ib 03 medical and health sciences symbols.namesake Internal medicine Genetics medicine Humans Aged Neoplasm Staging Retrospective Studies business.industry Proportional hazards model Health Status Disparities medicine.disease Black or African American Neoplasm Grading business Safety-net Providers Follow-Up Studies |
Zdroj: | BMC Cancer BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021) |
DOI: | 10.21203/rs.3.rs-48135/v1 |
Popis: | Background The Will Rogers phenomenon [WRP] describes an apparent improvement in outcome for patients’ group due to tumor grade reclassification. Staging of cancers is important to select appropriate treatment and to estimate prognosis. The WRP has been described as one of the most important biases limiting the use of historical cohorts when comparing survival or treatment. The main purpose of this study is to assess whether the WRP exists with the move from the AJCC 7th to AJCC 8th edition in breast cancer [BC] staging, and if racial differences are manifested in the expression of the WRP. Methods This is a retrospective analysis of 300 BC women (2007–2017) at an academic medical center. Overall survival [OS] and disease-free survival [DFS] was estimated by Kaplan-Meier analysis. Bi and multi-variate Cox regression analyses was used to identify racial factors associated with outcomes. Results Our patient cohort included 30.3% Caucasians [Whites] and 69.7% African-Americans [Blacks]. Stages I, II, III, and IV were 46.2, 26.3, 23.1, and 4.4% of Whites; 28.7, 43.1, 24.4, and 3.8% of Blacks respectively, in anatomic staging (p = 0.043). In prognostic staging, 52.8, 18.7, 23, and 5.5% were Whites while 35, 17.2, 43.5, and 4.3% were Blacks, respectively (p = 0.011). A total of Whites (45.05% vs. 47.85%) Blacks, upstaged. Whites (16.49% vs. 14.35%) Blacks, downstaged. The remaining, 38.46 and 37.79% patients had their stages unchanged. With a median follow-up of 54 months, the Black patients showed better stage-by-stage 5-year OS rates using 8th edition compared to the 7th edition (p = 0.000). Among the Whites, those who were stage IIIA in the 7th but became stage IB in the 8th had a better prognosis than stages IIA and IIB in the 8th (p = 0.000). The 8th showed complex results (p = 0.176) compared to DFS estimated using the 7th edition (p = 0.004). Conclusion The WRP exists with significant variability in the move from the AJCC 7th to the 8th edition in BC staging (both White and Black patients). We suggest that caution needs to be exercised when results are compared across staging systems to account for the WRP in the interpretation of the data. |
Databáze: | OpenAIRE |
Externí odkaz: |